Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shoulder dye could sharpen MRI images

NCT ID NCT07057037

Diagnosis Sponsor: Inventera Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new injection called NEMO-103 to see if it makes shoulder MRI pictures clearer for diagnosing problems like torn tendons or cartilage. About 85 adults with known or suspected shoulder issues will get both a regular MRI and one with the injection. The goal is to see if the dye improves image quality to help doctors make better diagnoses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 85 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥19 years at the time of informed consent. 2. Suspected or known shoulder joint diseases requiring MRA for diagnosis or evaluation at screening. 3. Voluntarily decided to participate in the study and provided written consent after receiving a sufficient explanation about this study and after fully understanding the information. Exclusion Criteria: 1. Subjects with contraindications to MRI 2. Subjects expected to be clinically unstable during the study 3. Subjects who have received or used another IP or investigational device within 4 weeks or ≥5 half-lives, whichever is longer, prior to informed consent. 4. Pregnant or breast-feeding women, or women of childbearing potential and men who do not agree to use appropriate methods of contraception during the study. 5. Determined to be ineligible to participate in the study by the investigator due to any other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesive capsulitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

articular cartilage disorder bursitis frozen shoulder Rotator Cuff Injuries rotator cuff syndrome tendinitis tendinosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adhesive capsulitis Articular cartilage injury Glenohumeral ligament Labral tear Long head biceps tendon tear Rotator cuff tear Rotator cuff tendinosis Rotator cuff tendonitis

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, Seoul Teugbyeolsi, 5505, South Korea

  • Gangnam Severance Hospital

    Seoul, Seoul Teugbyeolsi, 06273, South Korea

  • Konkuk University Medical Center

    Seoul, Seoul Teugbyeolsi, 05030, South Korea

  • Korea University Guro Hospital

    Seoul, Seoul Teugbyeolsi, 08308, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Seoul National University Hospital

    Seoul, Seoul Teugbyeolsi, 0308, South Korea

  • The Catholic University of Korea Seoul ST. Mary's Hospital

    Seoul, Seoul Teugbyeolsi, 06591, South Korea

  • Yonsei University Health System, Severance Hospital

    Seoul, Seoul Teugbyeolsi, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.